100 related articles for article (PubMed ID: 30792164)
1. MT4-MMP Modulates the Expression of miRNAs in Breast Cancer Cells.
Cervantes-Garduño A; Zampedri C; Espinosa M; Maldonado V; Melendez-Zajgla J; Ceballos-Cancino G
Arch Med Res; 2018 Oct; 49(7):471-478. PubMed ID: 30792164
[TBL] [Abstract][Full Text] [Related]
2. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.
Huang CH; Yang WH; Chang SY; Tai SK; Tzeng CH; Kao JY; Wu KJ; Yang MH
Neoplasia; 2009 Dec; 11(12):1371-82. PubMed ID: 20019845
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms Driven by MT4-MMP in Cancer Progression.
Muñoz-Sáez E; Moracho N; Learte AIR; Collignon A; Arroyo AG; Noel A; Sounni NE; Sánchez-Camacho C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373092
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.
Chabottaux V; Ricaud S; Host L; Blacher S; Paye A; Thiry M; Garofalakis A; Pestourie C; Gombert K; Bruyere F; Lewandowsky D; Tavitian B; Foidart JM; Duconge F; Noel A
J Cell Mol Med; 2009 Sep; 13(9B):4002-13. PubMed ID: 19426156
[TBL] [Abstract][Full Text] [Related]
5. The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects.
Host L; Paye A; Detry B; Blacher S; Munaut C; Foidart JM; Seiki M; Sounni NE; Noel A
Int J Cancer; 2012 Oct; 131(7):1537-48. PubMed ID: 22262494
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cells.
Truong A; Yip C; Paye A; Blacher S; Munaut C; Deroanne C; Noel A; Sounni NE
FEBS J; 2016 Feb; 283(4):704-22. PubMed ID: 26663028
[TBL] [Abstract][Full Text] [Related]
7. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
Chabottaux V; Sounni NE; Pennington CJ; English WR; van den Brûle F; Blacher S; Gilles C; Munaut C; Maquoi E; Lopez-Otin C; Murphy G; Edwards DR; Foidart JM; Noël A
Cancer Res; 2006 May; 66(10):5165-72. PubMed ID: 16707440
[TBL] [Abstract][Full Text] [Related]
8. MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
Yip C; Foidart P; Somja J; Truong A; Lienard M; Feyereisen E; Schroeder H; Gofflot S; Donneau AF; Collignon J; Delvenne P; Sounni NE; Jerusalem G; Noël A
Br J Cancer; 2017 Mar; 116(6):742-751. PubMed ID: 28196064
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo.
Blanco MJ; Rodríguez-Martín I; Learte AIR; Clemente C; Montalvo MG; Seiki M; Arroyo AG; Sánchez-Camacho C
PLoS One; 2017; 12(9):e0184767. PubMed ID: 28926609
[TBL] [Abstract][Full Text] [Related]
10. Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice.
Srichai MB; Colleta H; Gewin L; Matrisian L; Abel TW; Koshikawa N; Seiki M; Pozzi A; Harris RC; Zent R
PLoS One; 2011 Feb; 6(2):e17099. PubMed ID: 21347258
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
12. EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.
Paye A; Truong A; Yip C; Cimino J; Blacher S; Munaut C; Cataldo D; Foidart JM; Maquoi E; Collignon J; Delvenne P; Jerusalem G; Noel A; Sounni NE
Cancer Res; 2014 Dec; 74(23):6758-70. PubMed ID: 25320013
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C
Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using beta-galactosidase.
Rikimaru A; Komori K; Sakamoto T; Ichise H; Yoshida N; Yana I; Seiki M
Genes Cells; 2007 Sep; 12(9):1091-100. PubMed ID: 17825051
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
16. MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases.
Yip C; Foidart P; Noël A; Sounni NE
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654475
[TBL] [Abstract][Full Text] [Related]
17. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs.
Sun DW; Zhang HD; Mao L; Mao CF; Chen W; Cui M; Ma R; Cao HX; Jing CW; Wang Z; Wu JZ; Tang JH
Cell Physiol Biochem; 2015; 37(5):1693-711. PubMed ID: 26545287
[TBL] [Abstract][Full Text] [Related]
18. Expression and Characterization of Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) and its Different Forms in Melanoma.
Hieronimus B; Pfohl J; Busch C; Graeve L
Cell Physiol Biochem; 2017; 42(1):198-210. PubMed ID: 28531887
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
[TBL] [Abstract][Full Text] [Related]
20. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
